Understanding how bacteria control their cell division process
Deciphering the molecular circuitry that controls cell cycle progression in bacteria
This study is looking at how a protein called DnaA helps bacteria like Caulobacter crescentus manage their growth and division, with the hope of finding new ways to stop harmful bacteria from multiplying and causing infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10700095 on NIH RePORTER |
What this research studies
This research investigates the mechanisms that bacteria use to coordinate their cell cycle, focusing on the role of a specific protein called DnaA. By studying the bacterium Caulobacter crescentus, the researchers aim to uncover how DnaA influences chromosome replication and segregation, which are critical for cell survival. The project employs advanced molecular biology techniques to analyze the interactions between DnaA and the bacterial chromosome throughout the cell cycle. The ultimate goal is to identify potential drug targets that could help combat bacterial infections by disrupting their cell division processes.
Who could benefit from this research
Good fit: Patients with bacterial infections that are resistant to current antibiotic treatments may benefit from this research.
Not a fit: Patients with viral infections or non-infectious diseases are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that effectively target bacterial cell division.
How similar studies have performed: Other research has shown promise in targeting bacterial cell division mechanisms, indicating that this approach could lead to significant advancements in antibiotic development.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Mera, Paola E — University of Illinois at Urbana-Champaign
- Study coordinator: Mera, Paola E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.